Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | UNK | Unknown | — |
Patient received last dose of Vivotif two weeks after the expiry date 30-Jun-2024; Case reference number US-BN-2024-002185 is a spontaneous case initially received from a pharmacist via agency (reference number: USBAV24-1634) on 12-Jul-2024 and concerns a patient of unknown age and gender. The patient's medical history and concomitant medication were not provided. On an unspecified date, the patient took the last dose of Vivotif (batch number: unknown, expiry date: 30-Jun-2024) two weeks after the expiry date, at an unknown dose or route, for unknown indication (explicitly coded as 'expired vaccine used'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240712-3e4d91 to US-BAVARIAN NORDIC A/S-US-BN-2024-002185, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A patient of unknown age and gender took the last dose of Vivotif (expiry date: 30-Jun-2024) two weeks after the expiry date, for unknown indication, which is considered as expired vaccine used. It was unknown if the patient experienced any adverse event due to Vivotif. Expired product administered is considered as listed per company convention. The patient's medical history and concomitant medication were not provided. Expired product administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown age and gender took the last dose of Vivotif (expiry date: 30-Jun-2024) two weeks after the expiry date, for unknown indication, which is considered as expired vaccine used. It was unknown if the patient experienced any adverse event due to Vivotif. Expired product administered is considered as listed per company convention. The patient's medical history and concomitant medication were not provided. Expired product administered is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.